Product Finder

Product Finder

GMP Quality

With over 25 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space.

Sartorius CellGenix was the first company to obtain a GMP manufacturing authorization for therapeutic cell processing in Europe. Being an ATMP manufacturer ourselves allowed us to gain in-depth cell culture knowledge and superior regulatory expertise. With this unique background we understand the high requirements you face during product development and the regulatory approval process. We can help simplify your raw material qualificatition and validation efforts by offering expert technical and regulatory support. 

 

We are able to guarentee a consistent high product quality as all relevant GMP guidelines are followed for each step from initial development to final Quality Control (QC) release after manufacturing.

Our GMP grade raw materials offer a maximum of quality and safety due to state-of-the-art production, stringent quality control and comprehensive documentation.

Read more

Safe │ GMP Compliant │ Reliable 

GMP Quality

With over 25 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space.

Our GMP grade raw materials offer a maximum of quality and safety due to state-of-the-art production, stringent quality control and comprehensive documentation.

Read more 

 

News

  • Jul 2021

    Sartorius Acquires Majority Stake in Cell and Gene Therapy Raw Materials Supplier CellGenix

    CellGenix headquarters in Freiburg to be expanded into a center of excellence for the development and production of high quality raw materials for the cell and gene therapy market.

    Read more

  • Apr 2021

    New eBook on Raw Materials for CAR-T Production

    In collaboration with RegMedNet CellGenix published an eBook on Raw Materials for CAR-T Production. Find out why it is important to avoid the use of serum in your CAR-T manufacturing process and how different parameters influence the final CAR-T cell product.

    Read more

  • Apr 2021

    CellGenix Appoints Daniel Spatz as Vice President Sales, Marketing & Logistics and Member of the Management Team

    CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, is pleased to announce the appointment of Daniel Spatz as Vice President of Sales, Marketing and Logistics and member of the management team.

    Read more

Events